Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells

Haematologica

Volumn 92, Issue 3, 2007, Pages 332-341

  Bruserud, Øystein ^a   Ryningen, Anita ^a   Olsnes, Astrid Marta ^c   Stordrange, Laila ^b   Øyan, Anne Margrete ^a   Kalland, Karl Henning ^c   Gjertsen, Björn Tore ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute myelogenous; Chemokine; CXCR2; Leukemia; NFKB

Indexed keywords

CD34 ANTIGEN; CHEMOKINE; CHEMOKINE CCL22; CHEMOKINE CCL23; CHEMOKINE CCL24; CHEMOKINE CCL4; CHEMOKINE RECEPTOR; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL6 CHEMOKINE; CXCL9 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 3; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; STEM CELL FACTOR; THYMIDINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRITIUM; UNCLASSIFIED DRUG; BORONIC ACID DERIVATIVE; BORTEZOMIB; HYBRID PROTEIN; PYRAZINE DERIVATIVE; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CELL PROLIFERATION; CELL SUSPENSION; CHEMOTAXIS; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MALE; PATIENT CODING; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; ACUTE DISEASE; BIOSYNTHESIS; CELL DIVISION; CLASSIFICATION; COMPARATIVE STUDY; DNA REPLICATION; DRUG EFFECT; DRUG SCREENING; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; SECRETION; T LYMPHOCYTE; TUMOR CELL LINE;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BORONIC ACIDS; CELL DIVISION; CELL LINE, TUMOR; CHEMOKINES; CHEMOTAXIS; DNA REPLICATION; FEMALE; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NF-KAPPA B; PYRAZINES; RECEPTORS, CHEMOKINE; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; TUMOR STEM CELL ASSAY;

EID: 33847368129     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10148     Document Type: Article

References (24)

1. Bendall L. Chemokines and their receptors in disease. Histol Histopathol 2005; 20:907-26.
2. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M. Chemokines in tumor progression and metastasis. Cancer Sci 2005;96: 317-22.
3. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50.
4. Rosenkilde MM, Schwartz TW. The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 2004;112:481-95.
5. Allavena P, Marchesi F, Mantovani A. The role of chemokines and their receptors in tumor progression and invasion: potential new targets of biological therapy. Curr Cancer Ther Rev 2005;1:81-92.
6. Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 2004; 50:197-222.
7. Spoo A, Lübbert M, Wierda WG, Burger JA. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 2007; 109/86-91.
8. Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004;18:115-36.
9. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17: 3835-49.
10. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, Gjertsen BT, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118:217-28.
11. Bruserud Ø, Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. Haematologica 2004;89:391-402.
12. Bruserud Ø, Hovland R, Wergeland L, Huang TS, Gjertsen BT. Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. Haematologica 2003; 88:416-28.
13. Olsnes AM, Motorin D, Ryningen A, Zaritskey A, Bruserud Ø. T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC). Cancer Immunol Immunother 2006; 55:830-40.
14. Hovland R, Gjertsen BT, Bruserud Ø. Acute myelogenous leukemia with internal tandem duplication of the Flt3 gene appearing or altering at the time of relapse: a report of two cases. Leuk Lymphoma 2002;43: 2027-9.
15. Bruserud Ø, Gjertsen BT, von Volkman HL. In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res 2000;9:923-32.
16. Yang J, Amiri KI, Burke JR, Schmid JA, Richmond A. BMS-345541 targets inhibitor of kB kinase and induces apoptosis in melanoma: involvement of nuclear factor kB and mitochondria pathways. Clin Cancer Res 2006;12: 950-60.
17. Bhattacharyya GK, Johnson RA. Statistical concepts and methods. John Wiley & Sons. 1977.
18. Wold S, Esbensen K, Geladi P. Principal component analysis. Chemom Intell Lab Syst 1987;2:37-52.
19. Fellenberg K, Hauser NC, Brors B, Neutzner K, Hoheisel JD, Vingron A. Correspondence analysis applied to microarray data. Proc Natl Acad Sci USA 2001;11:10781-6.
20. Øyan AM, Bo TH, Jonassen I, Ulvestad E, Gjertsen BT, Kalland KH, et al. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry B Clin Cytom 2005; 64:18-27.
21. Aggarwal BB. Nuclear factor-kB: the enemy within. Cancer Cell 2004;6:203-8.
22. Hayden MS, Ghosh S. Signaling to NFkB. Genes Dev 2004;18:2195-224.
23. Bruserud Ø, Gjertsen BT, Foss B, Huang TS. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells-the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells 2001; 19:1-11.
24. Rombouts EJ, Pavic B, Lowenberg B, Ploemacher RE. Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood 2004; 104:550-7.